IMNN: R&D Day Highlights IMNN-001 Data in Frontline Ovarian Cancer

92 Views02 Oct 2026 04:00

Issuer-paid

On September 23, 2026, Imunon, Inc. (IMNN) held an R&D day to review the results for the IMNN-001 program in newly diagnosed advanced ovarian...

What is covered in the Full Insight:

SUMMARY

(Sign Up to Access)

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Full Insight

(Paid Plans Only, 10-minute read)

Discussions

(Paid Plans Only)

Price Chart(Sign Up to Access)

Insight Stream